In this recent @ThrombUpdate article, the authors evaluated effectiveness and safety of edoxaban for #VTE management in South Korea and Taiwan.
Read more here:
https://t.co/kKvz1Ver6T
@LucyNORTCD#TruJournal
This recent paper in @ThrombUpdate examined the association of #VTE with known risk factors and the impact of VTE on mortality in White, Black and Asian elderly non-Hodgkin lymphoma #NHL patients.
Read more here:
https://t.co/KhrBZLAkT8
@LucyNORTCD#TruJournal
In this recent systematic review, the authors performed economic evaluation of outpatient specialized models of care versus usual care for venous thromboembolism management.
Read more here:
https://t.co/AoSZiU46bB
@LucyNORTCD#TruJournal
In this recent @ThrombUpdate manuscript, the authors found that baseline low-grade systemic inflammation is associated with the long-term risk of hospitalized #VTE in the general population.
Read more here:
https://t.co/hkOIJaruvF
@LucyNORTCD#TruJournal
This recent paper in @ThrombUpdate reports selective intrinsic pathway activation in early claudication, whereas paradoxically suppressed #thrombin generation in advanced ischemia.
Read more here:
https://t.co/TGs3dqkW3T
@LucyNORTCD#TruJournal
New article in @ThrombUpdate ..
Researchers suggest that patients with multiple or high-titer antiphospholipid antibodies face a seven to 21-fold increased risk of severe mental illness. #APS#TruUpdate
Read more here:
https://t.co/heNC5CxLne
@LucyNORTCD
In this recent @ThrombUpdate article, the authors evaluated geriatric characteristics and outcomes of older patients diagnosed with acute #PE in the emergency department.
Read more here:
https://t.co/oocQDQbMhZ
@LucyNORTCD#TruJournal
In this latest @ThrombUpdate article, the authors determine the etiology, treatment, and prognosis of Splenic Infarcts.
Read more here:
https://t.co/8q0n5tvRNn
@LucyNORTCD#TruJournal
This review in @ThrombUpdate synthesizes #DOAC monitoring data and target concentrations in high-risk populations to guide the design of future clinical trials.
Read more here:
https://t.co/MrSXmeFfWp
@LucyNORTCD#TruJournal
In this recent @ThrombUpdate study, the authors examined sex differences in clinical characteristics, management, and outcomes in patients with #VTE from the COMMAND VTE Registry-2
Read more here:
https://t.co/M8LCXS1fnG
@LucyNORTCD#TruJournal
In this recent @ThrombUpdate article, the authors assessed clinical and therapeutic differences among anticoagulated patients across stages of renal dysfunction.
Read more here:
https://t.co/3N5cDsiCeP
@LucyNORTCD#TruJournal
In a recent @ThrombUpdate article, the authors show that the Pathfast D-dimer assay is a rapid POC test for determination of D-dimer with good analytical performance.
Read more here:
https://t.co/X1BuwgyW1R
@LucyNORTCD#TruJournal
New article in @ThrombUpdate ..
Researchers suggest that patients with multiple or high-titer antiphospholipid antibodies face a seven to 21-fold increased risk of severe mental illness. #APS#TruUpdate
Read more here:
https://t.co/heNC5CxLne
@LucyNORTCD
New article in @ThrombUpdate
"A scoping review protocol on active drug monitoring of direct oral anticoagulants on vulnerable patient groups to detect potential adverse risks"
Read more here:
https://t.co/vSZSPucqe0
@LucyNORTCD#TruJournal
Here is the editorial commentary on this article by @ThrombUpdate editors @LucyNORTCD and @emmpapadoc
"The risk of venous thromboembolism behind bars"
https://t.co/lzXfOcMwG7
#TruJournal
New article in @ThrombUpdate π
Findings from a phase 2 trial show that Auxoraβ’ may help patients with severe #COVID19 by reducing D-dimer levels.
@LucyNORTCD#TruJournal
Rear more here:
https://t.co/fwiU8iUdv2
A new study in @ThrombUpdate reveals what patients value in thrombosis care!
Clear info & respectful relationships are key to satisfaction, but virtual options and affordable medication are areas for improvement.
@LucyNORTCD#TruJournal
Read more here:
https://t.co/Bm87es6BTQ
A new study in @ThrombUpdate shows that freezing plasma samples doesn't significantly affect #thrombin generation measurements over long-term storage (up to 2 years at -80Β°C).
@LucyNORTCD#TruJournal
Read more here:
https://t.co/8IpJ9WFcuL
A new multicenter study in @ThrombUpdate from Colombia characterizes anticoagulation reversal practices, revealing bleeding as the primary indication and warfarin as the most common anticoagulant.
@LucyNORTCD#TruJournal
Read more here:
https://t.co/TK1AnePesn